Live Terminal | Security Analysis of REGN
TERMINAL beta
Version: 0.1
Timestamp: 1709191625.274649
Options
0Q3.F
53.76%
006220.KS
49.51%
B7J.DE
48.43%
000540.KS
48.07%
BBAI-WT
47.26%
HANA.L
-44.06%
PHLL.L
-50.14%
RAL.PA
-52.20%
GOLL4.SA
-52.40%
HGEN.L
-54.91%
AAPL $180.88 -0.96%
AMD $176.37 -0.92%
AMZN $173.96 0.24%
BRK-B $413.02 1.01%
GOOG $137.26 -2.03%
IBM $184.92 0.03%
INTC $42.16 -1.35%
JNJ $161.21 0.14%
JPM $184.74 0.70%
META $487.18 0.03%
MSFT $407.70 0.05%
O $52.16 -0.28%
TSLA $203.55 1.91%
WMT $59.72 0.21%
QQQ $435.27 -0.5325%
TLT $93.52 0.6349%
VUSA.DE $88.94 0.3317%
VUAA.DE $88.27 0.2863%
FJPR.L $5.63 -0.5650%
VWRP.L $97.51 -0.0102%
VWRL.L $98.20 0.0255%
EMGU.L $3.55 -1.1847%
RDVY $52.62 -0.1518%
FLOT $51.04 0.0294%
SCHZ $45.68 0.2414%
IBB $139.42 -1.0434%
C020.DE $21.34 0.0000%
DFAX $24.53 -0.6480%
LYP6.DE $224.95 -0.3985%
MEUD.PA $225.01 -0.2880%
IQQW.DE $65.41 0.0643%
IDWR.L $70.89 -0.0775%
EXS1.DE $147.20 0.2452%
XESC.L $6900.00 0.0290%
DFAU $35.18 -0.2269%
ACWV $103.29 -0.3377%
VHYD.L $63.68 -0.2897%
VGWD.DE $58.77 -0.1699%
FXKZ.ME $303.00 0.0000%

Latest articles

REGN Regeneron Posts Strong Q4 Earnings

Feb. 2, 2024, 11:09 a.m.

Image for article: Regeneron Posts Strong Q4 Earnings
Sentiment statistics ?
REGN
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
REGN
Latest Performance
REGN$991.15
$-2.19 • -0.22%
REGN
Price 991.15
Change Pct -0.22
Change Abs -2.19
Market Cap 107.0 billion
Eps 34.80
Pe Ratio 28.48
Outstanding Shares 107.9 million
Volume 184189
Avg Volume 576252
Industry Biotechnology
Sector Name Health Care
Country Short Name US
Announcement Earnings 2024-05-02 00:00:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
REGN

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization;